These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6308842)

  • 1. Alpha-adrenergic receptors in platelets from patients with Raynaud's syndrome.
    Keenan EJ; Porter JM
    Surgery; 1983 Aug; 94(2):204-9. PubMed ID: 6308842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha 2-adrenergic receptor levels in obstructive and spastic Raynaud's syndrome.
    Edwards JM; Phinney ES; Taylor LM; Keenan EJ; Porter JM
    J Vasc Surg; 1987 Jan; 5(1):38-45. PubMed ID: 3025464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of digital artery adrenoceptors in Raynaud's disease.
    Cooke JP; Creager SJ; Scales KM; Ren C; Tsapatsaris NP; Beetham WP; Creager MA
    Vasc Med; 1997; 2(1):1-7. PubMed ID: 9546943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptoms of Raynaud's syndrome in patients with fibromyalgia. A study utilizing the Nielsen test, digital photoplethysmography, and measurements of platelet alpha 2-adrenergic receptors.
    Bennett RM; Clark SR; Campbell SM; Ingram SB; Burckhardt CS; Nelson DL; Porter JM
    Arthritis Rheum; 1991 Mar; 34(3):264-9. PubMed ID: 1848429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenoceptors on blood cells from patients with primary Raynaud's phenomenon.
    Graafsma SJ; Wollersheim H; Droste HT; ten Dam MA; van Tits LJ; Reyenga J; Rodrigues de Miranda JF; Thien T
    Clin Sci (Lond); 1991 Apr; 80(4):325-31. PubMed ID: 1851068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating nerve growth factor in primary and secondary Raynaud's syndrome - results of a pilot study.
    Klein-Weigel P; Gutsche-Petrak B; Humpel C; Riemekasten G; Ivanov S; Heidrich H
    Vasa; 2009 Feb; 38(1):39-45. PubMed ID: 19229802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of platelet function in patients with Raynaud's syndrome.
    Hutton RA; Mikhailidis DP; Bernstein RM; Jeremy JY; Hughes GR; Dandona P
    J Clin Pathol; 1984 Feb; 37(2):182-7. PubMed ID: 6229551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma eicosanoids, platelet function and cold sensitivity.
    Wilkinson D; Vowden P; Gilks L; Latif AB; Rajah SM; Kester RC
    Br J Surg; 1989 Apr; 76(4):401-5. PubMed ID: 2720355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin and Raynaud's phenomenon.
    Seibold JR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S95-8. PubMed ID: 2412070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Finger plethysmography for studying the blood rheological and hemodynamic components of an acrosyndrome].
    de Faucal P; Planchon B; Boudard D; Peltier P; Barrier J; Grolleau JY
    J Mal Vasc; 1986; 11(4):356-61. PubMed ID: 3805897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Raynaud's syndrome: study of fingertip blood flow by plethysmography with venous occlusion (author's transl)].
    Cristol R; Graisely B; Cloarec M; Debray J
    Nouv Presse Med; 1979 Jan; 8(2):105-8. PubMed ID: 554069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased number of alpha-adrenergic receptors in platelets of patients on maintenance haemodialysis.
    Brodde OE; Daul A; Graben N
    Proc Eur Dial Transplant Assoc; 1983; 19():270-4. PubMed ID: 6308599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis].
    Serri J; Legré R; Veit V; Guardia C; Gay AM
    Ann Chir Plast Esthet; 2013 Dec; 58(6):658-62. PubMed ID: 22204894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical significance of Raynaud's syndrome.
    Porter JM; Bardana EJ; Baur GM; Wesche DH; Andrasch RH; Rösch J
    Surgery; 1976 Dec; 80(6):756-64. PubMed ID: 1006524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Raynaud's phenomenon with captopril.
    Tosi S; Marchesoni A; Messina K; Bellintani C; Sironi G; Faravelli C
    Drugs Exp Clin Res; 1987; 13(1):37-42. PubMed ID: 3297593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased alpha-adrenergic responsiveness in idiopathic Raynaud's disease.
    Freedman RR; Sabharal SC; Desai N; Wenig P; Mayes M
    Arthritis Rheum; 1989 Jan; 32(1):61-5. PubMed ID: 2536282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in red cell behaviour between patients with Raynaud's phenomenon and systemic sclerosis and patients with Raynaud's disease.
    Rustin MH; Kovacs IB; Sowemimo-Coker SO; Maddison PJ; Kirby JD
    Br J Dermatol; 1985 Sep; 113(3):265-72. PubMed ID: 3877518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactive hyperemia in Raynaud's disease.
    Pratesi F; Corsi C; Deidda C; Nuti A
    Biochem Exp Biol; 1977; 13(3):337-9. PubMed ID: 16296018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cold-induced potentiation of alpha 2-adrenergic vasoconstriction in primary Raynaud's disease.
    Freedman RR; Moten M; Migály P; Mayes M
    Arthritis Rheum; 1993 May; 36(5):685-90. PubMed ID: 8387786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laser Doppler skin perfusion pressure in the assessment of Raynaud's phenomenon.
    Kanetaka T; Komiyama T; Onozuka A; Miyata T; Shigematsu H
    Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):414-6. PubMed ID: 15015193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.